CALC

CalciMedica, Inc.

2.26 USD

Last updated Sep 12, 01:25 UTC

Yesterday HIGH

$2.27

Yesterday LOW

$2.09

52w HIGH

$36

52w LOW

$1.91

EPS

-2.25

PE

-1.00

Next Earnings

Nov 11, 2026

Overview News Insider Transactions Government Trades Fundamentals

CalciMedica, Inc. stock is down -27.26% since 30 days ago. The next earnings date is Nov 11, 2026. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 September’s closed higher than August. 100% of analysts rate it a buy.

Benzinga Newsdesk

Fri Jul 24, 2026

CalciMedica Files Prospectus For Resale Of Up To 56,020,287 Shares

https://www.sec.gov/Archives/edgar/data/1534133/000119312526316100/d169379ds3.htm
Benzinga Insights

Fri Jun 26, 2026

12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $1.8 million. Tvardi Therapeutics
Benzinga Insights

Fri Jun 26, 2026

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. The company's, Q1 earnings came out 4
Benzinga Insights

Wed Jun 24, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's regular session. The market value of their outstanding shares is at $22.1 million. Icecure Medical (NASDAQ:ICCM) stock
Vandana Singh

Wed Jun 24, 2026

FDA Raises No Concerns Over Auxora Safety Data, CalciMedica Advances Trial

FDA raises no objections to CalciMedica revised Phase 2 KOURAGE trial, allowing Auxora dosing to resume for acute kidney injury.
Benzinga Newsdesk

Wed Jun 24, 2026

Market-Moving News for June 24th

FDX: -7% | FedEx shares are trading lower. The company reported Q4 financial results. LFS: 42% | LEIFRAS shares are trading higher after the company announced it will acquire SWIFT JAPAN. CALC: 60% | CalciMedica
Benzinga Newsdesk

Wed Jun 24, 2026

CalciMedica Announces Private Placement Worth Up To ~$49M In Gross Proceeds

The financing includes participation from new and existing investors, including members of CalciMedica's Board of Directors and management team. In the private placement, the Company will sell an aggregate of
Benzinga Newsdesk

Wed Jun 24, 2026

CalciMedica Receives No FDA Comments On The Submission Packet For Its Phase 2 KOURAGE Trial, Meaning The Company May Continue To Dose Patients With Auxora

CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for
Benzinga Insights

Fri Jun 5, 2026

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Newsdesk

Tue May 12, 2026

CalciMedica Q1 EPS $0.30 Beats $(0.28) Estimate

CalciMedica (NASDAQ:CALC) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $(0.28) by 207.14 percent. This is a 183.33 percent increase over losses of $(0.36) per share from the

Guggenheim

Thu Aug 20, 15:11

buy

initial

Advanced Data Unlock

ALAFI CAPITAL CO LLC, Insider

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

7,058,384 shares awarded
Allan Shaw, Insider

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

10,000 shares awarded
Alan Glicklich, Insider

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

10,000 shares awarded
Frederic Guerard, Insider

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

10,000 shares awarded
Evgeny Zaytsev, Insider

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

2,900,534 shares awarded
Evgeny Zaytsev, Insider

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

10,000 shares awarded
ROBERT WILSON, Retired Director/Vice Chairman

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

2,365,242 shares awarded
ROBERT WILSON, Retired Director/Vice Chairman

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

10,000 shares awarded
Sudarshan Hebbar, Chief Medical Officer

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

248,972 shares awarded
Eric Roberts, CHIEF BUSINESS OFFICER

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

373,458 shares awarded
Rachel Leheny, CHIEF EXECUTIVE OFFICER

Wed Aug 19, 2026

CALC Recent Insider Trades and Stock Chart

373,458 shares awarded